UK issues advice on breast implants:
This article was originally published in Clinica
Executive Summary
The UK Department of Health has issued advice on breast implantation detailing: alternative breast reconstruction options; current thinking on the short-term side-effects and long-term potential complications involved in implantation; the issue of pregnancy and breast-feeding; and economic implications. It also provides a checklist of the issues to be considered by prospective patients. The booklet addresses a recommendation from the UK Independent Review Group on silicone gel implants, which in July 1998 called for the provision of free and comprehensive information on breast implantation. Increased concerns over recent years have led to the banning of silicone implants in Canada (since 1992), the US and France. The UK, however, considers that there is insufficient evidence to support a ban.
You may also be interested in...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.
Beauty Firms Using AI-Based Tools Could Be Subject To Health Privacy Laws In US States
Using AI-based programs to collect and store consumer information risks running afoul of new health privacy laws cropping up in US states. Lack of federal regulation or guidance on the issue is one of the biggest challenges for beauty firms deploying AI, according to Stacy Marcus, partner at Reed Smith LLP.